Overview of the treatment of renal cell carcinoma - UpToDate
In patients with localized clear cell renal cell carcinoma (RCC) treated with nephrectomy, adjuvant immunotherapy is an established treatment option, but long-term data on overall survival (OS) were previously limited. In extended follow-up of a randomized trial in approximately 1000 patients with clear cell RCC treated with nephrectomy, one year of adjuvant pembrolizumab improved four-year OS compared with placebo (91 versus 86 percent) [1]. For patients with clear cell RCC at intermediate-high or high risk of disease recurrence following nephrectomy, we recommend adjuvant pembrolizumab. (See "Overview of the treatment of renal cell carcinoma", section on 'Approach to adjuvant therapy'.) Read more INTRODUCTION Renal cell carcinomas (RCCs), which originate within the renal cortex, constitute 80 to 85 percent of primary renal neoplasms. Urothelial (transitional cell) carcinomas of the renal pelvis account for approximately 8 percent of kidney tumors, and other parenchymal epithelial tum
UpToDate
Explore this link on the map →related reading
- Pancreatic Cancer - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
- Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
- 癌症治療的海豹特種部隊 淺談CAR-T細胞治療法::台灣癌症基金會canceraway.org.tw
- Cancer cells educate natural killer cells to a metastasis-promoting cell state - PubMedpubmed.ncbi.nlm.nih.gov
- Cancer cells educate natural killer cells to a metastasis-promoting cell state - PMCpmc.ncbi.nlm.nih.gov
- Immunotherapy in pediatric malignancies: current status and future perspectives - PMCncbi.nlm.nih.gov
- Immunotherapy for Cancer - NCIcancer.gov
- The blood cancer that became solvableworksinprogress.news
- Nasopharyngeal Carcinoma(Archived) - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
- 基因分子診斷實驗室ntuh.gov.tw
- Research advances in treatment strategies for breast cancer liver metastases: A comprehensive review - PMCpmc.ncbi.nlm.nih.gov
- Has pancreatic cancer met its match?worksinprogress.co